Last reviewed · How we verify

NCT06761716: NEPTUNE

Comparison of Ericksonian Hypnotherapy and CBT in PTSD: A Clinical Trial

Completed NA Last updated 5 June 2025
What this trial tests

NA trial testing Ericksonian Hypnotherapy in PTSD in 60 participants. Completed in 15 April 2025.

Timeline
15 November 2024
Primary endpoint
15 March 2025
15 April 2025

Quick facts

Lead sponsorUskudar University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date15 November 2024
Primary completion15 March 2025
Estimated completion15 April 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Uskudar University

Who can join

Adults 18 to 65, any sex, with PTSD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Brief Summary (Plain Language) The goal of this clinical trial is to compare the effects of Ericksonian Hypnotherapy and Cognitive Behavioral Therapy (CBT) on people diagnosed with Post-Traumatic Stress Disorder (PTSD). The study will also evaluate how these therapies impact brain activity, skin conductance, and heart rate. The main questions it aims to answer are: Does Ericksonian Hypnotherapy reduce PTSD symptoms as effectively as CBT? Do these therapies affect brain activity, skin conductance, and heart rate differently? Participants will be randomly assigned to one of two therapy groups: Ericksonian Hypnotherapy Group: Weekly 50-minute sessions for 12 weeks. CBT Group: Weekly 50-minute sessions for 12 weeks. To assess physiological and emotional responses, researchers will measure brain activity (EEG), skin conductance (GSR), and heart rate (HR) at various points. These assessments include a guided discussion task where participants reflect on their trauma in a controlled therapeutic environment. This task allows researchers to evaluate emotional regulation and stress markers in real time. This study aims to provide insight into the physiological and psychological impacts of both therapies on PTSD treatment, offering a deeper understanding of how these interventions influence neurophysiological stress responses.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Ericksonian Hypnotherapy

Trials testing the same drug.

Other recruiting trials for PTSD

Currently open trials in the same condition.

Other Uskudar University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06761716.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing